NCT01438281View on ClinicalTrials.gov

Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

June 30, 2012

Conditions
Ocular PainDry Eye
Interventions
DRUG

SYL1001

SYL1001 eye drops. topical administration

Trial Locations (1)

31008

Clinica Universidad de Navarra, Pamplona

All Listed Sponsors
lead

Sylentis, S.A.

INDUSTRY

NCT01438281 - Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers | Biotech Hunter | Biotech Hunter